C

Cyclacel Pharmaceuticals
D

CYCCP

8.39000
USD
2.62
(45.41%)
مغلق
حجم التداول
0
الربح لكل سهم
0
العائد الربحي
2.03
P/E
0
حجم السوق
2,812,940
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Cyclacel Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.